Category: MedTech
-
Clinical Evidence Requirements for Medtech: What You Need and When
Medical device companies face a complex landscape when determining their clinical evidence requirements. The path forward depends on multiple factors including device classification, predicate devices, and regulatory pathway. Understanding these requirements early in development can mean the difference between a smooth regulatory submission and costly delays. This oversight can derail product launches and strain resources… Read more
-
What Buyers Look For in a Regulatory Due Diligence Review
When private equity firms and strategic acquirers evaluate life sciences companies, the regulatory landscape often determines whether a promising deal moves forward or stalls indefinitely. Thorough regulatory due diligence can either validate an acquisition thesis or reveal hidden risks that fundamentally alter deal terms. For M&A buyers in the medtech, pharma, and nutraceutical sectors, understanding… Read more
-
Structure/Function Claims
Structure/Function Claims: What You Can and Cannot Say on Your Label When marketing dietary supplements, the line between permissible claims and regulatory violations can seem razor-thin. Structure/function claims represent one of the most powerful tools in your marketing arsenal, when used correctly. However, missteps in this area can trigger costly FDA enforcement actions and FTC… Read more
-
The Difference Between a Compliance Audit and a Regulatory Readiness Check
The Difference Between a Compliance Audit and a Regulatory Readiness Check Understanding the distinction between a compliance audit and a regulatory readiness check is crucial for companies navigating the complex world of FDA regulations. While both assessments evaluate your organization’s adherence to regulatory requirements, they serve different purposes, occur at different stages of your business… Read more
-
Why Compliance Is Your Competitive Advantage, Not Your Bottleneck
Why Compliance Is Your Competitive Advantage, Not Your Bottleneck Most founders and operations leaders view regulatory compliance as a necessary evil—a costly hurdle that slows down product launches and drains resources. This mindset fundamentally misunderstands the strategic value of a well-designed compliance strategy. Smart organizations transform compliance from a perceived bottleneck into a powerful driver… Read more
-
How FDA Regulations Differ for Pharma vs Medtech vs Nutraceuticals
How FDA Regulations Differ for Pharma vs Medtech vs Nutraceuticals: A Founder’s Guide For founders entering the health and wellness space, understanding FDA regulations is crucial for successful product launches and sustainable growth. The regulatory landscape varies significantly across pharmaceutical drugs, medical devices, and nutraceuticals, each with distinct pathways, requirements, and timelines. In our experience… Read more
-
QMSR vs ISO 13485: What Medtech Companies Need to Know in 2026
QMSR vs ISO 13485: What Medtech Companies Need to Know in 2026 Quality managers in the medical device industry face increasingly complex decisions about which quality management standards to implement and maintain. Two frameworks consistently emerge at the center of these discussions: the Quality Management System Regulation (QMSR) and ISO 13485. Understanding their differences, overlaps,… Read more
-
How to Determine Your Product’s Regulatory Classification
Understanding Your Product’s Place in the Regulatory Landscape When launching a medical device or health product, understanding your product classification serves as the foundation for every subsequent regulatory decision. This determination shapes your pathway to market, influences development timelines, and directly impacts your resource allocation strategy. In our year’s of experience working with medtech companies,… Read more
-
What Health & MedTech Founders Should Fix Before Starting M&A Conversations
What Founders Should Fix Before Starting M&A Conversations The M&A landscape for life science has never been more competitive. While strategic acquirers and private equity firms actively seek innovative medtech, pharma, and nutraceutical companies, they’re increasingly selective about the deals they make. In our experience working with companies through acquisition processes, the consistently same critical… Read more
-
Why Regulatory Readiness is the Most Overlooked Factor in M&A Valuations
When private equity firms and strategic acquirers evaluate life sciences companies, they typically focus on market size, intellectual property, and potential for financial performance. Yet one critical factor consistently gets relegated to the back burner: regulatory readiness. Our 25+ years of experience with medtech, pharma, and nutraceutical companies has caused us to witness how regulatory… Read more